Search by Drug Name or NDC
NDC 39822-3050-02 PENTAMIDINE ISETHIONATE 300 mg/3mL Details
PENTAMIDINE ISETHIONATE 300 mg/3mL
PENTAMIDINE ISETHIONATE is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by XGen Pharmaceuticals DJB, Inc.. The primary component is PENTAMIDINE ISETHIONATE.
MedlinePlus Drug Summary
Pentamidine injection is used to treat pneumonia caused by a fungus called Pneumocystis carinii. It is in a class of medications called antiprotozoals. It works by stopping the growth of protozoa that can cause pneumonia.
Related Packages: 39822-3050-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pentamidine Injection
Product Information
NDC | 39822-3050 |
---|---|
Product ID | 39822-3050_f913c6ad-1490-8fd8-e053-6294a90a6ab2 |
Associated GPIs | |
GCN Sequence Number | 009599 |
GCN Sequence Number Description | pentamidine isethionate VIAL 300 MG INJECTION |
HIC3 | W4K |
HIC3 Description | ANTIPROTOZOAL DRUGS,MISCELLANEOUS |
GCN | 42990 |
HICL Sequence Number | 004162 |
HICL Sequence Number Description | PENTAMIDINE ISETHIONATE |
Brand/Generic | Generic |
Proprietary Name | PENTAMIDINE ISETHIONATE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | PENTAMIDINE ISETHIONATE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route | INTRAMUSCULAR; INTRAVENOUS |
Active Ingredient Strength | 300 |
Active Ingredient Units | mg/3mL |
Substance Name | PENTAMIDINE ISETHIONATE |
Labeler Name | XGen Pharmaceuticals DJB, Inc. |
Pharmaceutical Class | Antiprotozoal [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206982 |
Listing Certified Through | 2024-12-31 |
Package
NDC 39822-3050-02 (39822305002)
NDC Package Code | 39822-3050-2 |
---|---|
Billing NDC | 39822305002 |
Package | 10 VIAL in 1 CARTON (39822-3050-2) / 3 mL in 1 VIAL |
Marketing Start Date | 2023-04-04 |
NDC Exclude Flag | N |
Pricing Information | N/A |